Output Factory Server for Adobe InDesign Now Supports CC 2014 Release

Zevrix Solutions announces Output Factory Server 1.0.17, a compatibility update to its output workflow automation solution for Adobe InDesign. Output Factory Server automates printing and exporting from InDesign by processing files from hot folders. The software offloads output tasks to a central system leaving operator workstations free from the output process. The new version makes Output Factory Server compatible with the 2014 release of InDesign CC featured as part of Adobe Creative Cloud.

Toronto (ON), Canada (July 17, 2014) -- Zevrix Solutions today announces the release of Output Factory Server 1.0.17, a compatibility update to its solution to automate printing, exporting and post-processing from Adobe InDesign. Developed originally for a major magazine publisher in the United States to free up their operator computers from outputting InDesign files, the software automates InDesign workflow by processing files from watched hot folders.

The new version makes Output Factory Server compatible with the recently announced 2014 release of InDesign CC, featured as part of Adobe Creative Cloud. The update is offered free of charge to Output Factory Server users. The same version of Output Factory Server can be used with any version of InDesign from CS3 and later.

"Output Factory Server is an extremely useful utility for a busy production facility or advertising agency", writes David Creamer in Layers magazine, "It can save lots of time - which equates to money."

Under Output Factory Server workflow, production artists, prepress operators and designers simply copy InDesign jobs to hot folders that reside on a network. Users can create hot folders for any type of output - for example hi-res PDF, large format printing, EPUB files and so on. Output Factory Server offers the following key features:

-Support for print, PDF, PostScript, EPS, JPEG, Flash, EPUB and other formats
-Variable output file names
-Preflight files before output
-Automatic e-mail notifications
-Serves unlimited users on a network

Pricing and Availability:
Output Factory Server can be purchased from Zevrix web site for US$699.95, as well as from authorized resellers. Trial is also available for download. BatchOutput Server users can upgrade for $350. Output Factory Server runs on Mac OS X 10.6-10.9 and works with Adobe InDesign CS3-CC 2014.

About Zevrix Solutions

Located in Toronto, Canada, Zevrix Solutions provides productivity solutions for Adobe Creative Suite software, PDF and graphic file diagnostics, file delivery and Microsoft Office on Mac OS. Zevrix Solutions is dedicated to helping professionals achieve more while doing less through automating their everyday tasks, producing error-free documents, saving disk space and cutting production costs. For more information, visit http://www.zevrix.com.

Contact:
Leo Revzin
Owner
Zevrix Solutions
105 McCAUL St, Suite 301
Toronto Ontario M5T 2X4 Canada
858-206-0607
Posted by No comments:

The Aerobika(R) Device, Marketed by Monaghan Medical in the United States, Benefits COPD Patients and Wins Gold at MDEA Awards

The Aerobika® Oscillating Positive Expiratory Pressure (OPEP) Therapy System marketed by Monaghan Medical Corporation has earned Gold at the Medical Design Excellence Awards (MDEA).

Plattsburgh, NY, USA (July 17, 2014) - The Aerobika® Oscillating Positive Expiratory Pressure (OPEP) Therapy System marketed by Monaghan Medical Corporation has earned Gold at the Medical Design Excellence Awards (MDEA). MDEA is an International Award recognizing groundbreaking products that save lives, improve patient healthcare, change the face of medical technology, and overcome design and engineering challenges. It is one of the medical technology industry's highest honors.

The Aerobika® Oscillating PEP device is a drug-free, easy to use, hand-held device that helps people with COPD, Cystic Fibrosis (CF) and other respiratory conditions to breathe easier and live better. COPD (Chronic Obstructive Pulmonary Disease) is the fourth leading cause of death globally and continues to grow in prevalence. Clinical evaluations conducted at Robarts Research Institute (Western University, London) demonstrated use of the device could significantly reduce breathlessness and improve patient's quality of life.

"When the Aerobika® Oscillating PEP Therapy System was created, the goal was to develop a product that addressed an unmet need for patients suffering from serious respiratory conditions, including COPD, CF, Bronchiectasis, Post Op and any patient with a productive cough requiring a non - pharmaceutical method to assist removing secretions from the lung. The innovation built into the Aerobika® OPEP device delivers excellent effectiveness while being very easy to use," states Dom Coppolo, Vice President of Clinical Affairs at Monaghan Medical Corporation. "The overall goal of the device is to ensure the patient can maintain their treatments to control their symptoms, breathe easier, enjoy a better quality of life and ultimately, stay out of the hospital."

The award was announced at the MDEA Awards Ceremony held on Wednesday, June 11, 2014 in New York City. Entries were evaluated by an impartial panel of industry experts comprised of practicing doctors, nurses, and technicians alongside industrial designers, engineers, manufacturers, and human factors experts. The Aerobika® Oscillating PEP device was deemed to excel in 5 evaluation criteria: manufacturing and technological innovation; design and engineering advancements; patient benefits; business benefits; and overall improvement to healthcare industry.

The Aerobika® Oscillating PEP device is available at many leading hospitals across the United States and by prescription from a physician. The Aerobika® Oscillating PEP device is marketed by Monaghan Medical Corporation in the United States. For more information about this story as well as image and video downloads, please visit: http://www.monaghanmed.com/news/aerobika-device-marketed-monaghan-medical-united-states-benefits-copd-patients-and-wins-gold-md.

About Monaghan Medical Corporation
Monaghan Medical Corporation (MMC), headquartered in Plattsburgh, New York (USA), is a leader in the development, manufacture and/or marketing of respiratory devices in the United States, such as the flagship AeroChamber® Brand of Valved Holding Chamber (VHC) for asthma patients. Its best-in-class respiratory management products are developed and validated at its affiliate's world-renowned Aerosol Lab. The respiratory management products it markets today and has marketed in the past in the United States are the subject of peer reviewed articles published in various medical journals, such as the New England Journal of Medicine, CHEST.

Contact:
Karen Teys
Director of Marketing
Monaghan Medical Corporation
800-343-9071
Posted by No comments:
Subscribe to: Posts (Atom)